BAY 59-3074

Chemical compound From Wikipedia, the free encyclopedia

BAY 59-3074 is a drug which is a cannabinoid receptor partial agonist developed by Bayer AG. It has analgesic effects and is used in scientific research. It is orally active in animals, and has modest affinity for both CB1 and CB2 receptors, with Ki values of 48.3nM at CB1 and 45.5nM at CB2.[1][2]

Legal status
  • In general: unscheduled
Quick facts Legal status, Identifiers ...
BAY 59-3074
Legal status
Legal status
  • In general: unscheduled
Identifiers
  • 3-[2-Cyano-3-(trifluoromethyl)phenoxy]phenyl 4,4,4-trifluoro-1-butanesulfonic acid ester
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC18H13F6NO4S
Molar mass453.36 g·mol−1
3D model (JSmol)
  • FC(F)(F)CCCS(=O)(=O)Oc2cc(Oc1cccc(c1C#N)C(F)(F)F)ccc2
  • InChI=1S/C18H13F6NO4S/c19-17(20,21)8-3-9-30(26,27)29-13-5-1-4-12(10-13)28-16-7-2-6-15(14(16)11-25)18(22,23)24/h1-2,4-7,10H,3,8-9H2 checkY
  • Key:LWUSZIVDPJPVBW-UHFFFAOYSA-N checkY
  (verify)
Close

References

Related Articles

Wikiwand AI